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Abbreviations
5hmC  5-Hydroxymethyl cytosine
5mC  5-Methyl cytosine
CGI  CpG island
eRv  endogenous retrovirus
eS cells  embryonic stem cells
H3K27Ac  Histone 3 lysine 27 acetylation
H3K27Me3  Histone 3 lysine 27 trimethylation
H3K4Me  Histone 3 lysine 4 methylation
H3K9Me3  Histone 3 lysine 9 trimethylation
H4K20Me3  Histone 4 lysine 20 trimethylation
IAP  Intracisternal A particle
LINe  Long interspersed nuclear element
LTR  Long terminal repeat
piRNA  PIwI-interacting RNA
SINe  Short interspersed nuclear element
siRNA  Small interfering RNA
Introduction
Maintaining genetic stability through the generations is 
key for the survival of all species. If the germline mutation 
rate is too low, there will not be sufficient variation within 
the species to adapt and survive over evolutionary time; 
yet, if the germline mutation rate is too high, the accumu-
lation of deleterious mutations will impact on viability. 
One of the major drivers of genetic change in the genome 
is retrotransposons. Retrotransposons are highly abundant 
mobile genetic elements that account for around 40 % of 
the sequenced mammalian genome [1, 2]. Retrotranspo-
sons contribute to genome instability by acting as sites for 
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recombination-mediated chromosomal deletions and re-
arrangements by influencing expression of nearby genes, 
and by causing mutations when new retrotransposition 
events disrupt pre-existing genetic information in the host 
genome [3].
For retrotransposons to be successful, retrotransposi-
tion must occur in the germ cells, or in the pluripotent cells 
from which germ cells arise. Germ cells and pluripotent 
cells have evolved multiple genome defence mechanisms 
to limit the mutagenic activity of these mobile genetic 
elements [4–6]. A number of genes involved in suppress-
ing retrotransposon activity in the mammalian germline 
have been identified, and the ways that these genome 
defence mechanisms are regulated and interact to provide 
an effective defence against retrotransposons are starting 
to be understood. In this review, we will describe the dif-
ferent types of retrotransposons in mammalian genomes, 
the mechanisms that germ cells and pluripotent cells use to 
suppress the activity of these elements, and the phenotypic 
defects that arise in the developing germ cells when ger-
mline genome defence genes are mutated.
Mammalian retrotransposons
The mammalian genome contains three major classes of 
retrotransposon: long interspersed nuclear element (LINe), 
short interspersed nuclear element (SINe), and long termi-
nal repeat (LTR) retrotransposons (Fig. 1) [1, 2]. each of 
these retrotransposon classes has different characteristics 
and properties.
LINe retrotransposons
LINe-1, which accounts for ~17 % of the sequenced 
genome, is the major family of LINe retrotransposons in 
mammals. Most copies of LINe-1 in mammalian genomes 
are 5′-truncated, probably due to incomplete reverse-tran-
scription of this element during retrotransposition [1, 2]. 
Full-length mouse and human LINe-1 elements are around 
6–7 kb in length and contain a variable internal promoter 
driving expression of these elements (Fig. 1). The inter-
nal promoter differs significantly in sequence between 
mouse and human LINe-1 elements, and between differ-
ent LINe-1 subfamilies within species [7–9]. LINe-1 pro-
moters may have been co-opted from host sequences, and 
differences between LINe-1 promoter sequences could 
lead to variations in the transcription factor requirements 
and regulation of these elements. The transcribed LINe-1 
mRNA encodes two proteins, ORF1 and ORF2, that are 
each required for LINe-1 retrotransposition [10, 11]. ORF1 
encodes a ~40-kDa nucleic acid-binding protein contain-
ing a central RNA recognition motif that has nucleic acid 
chaperone activity, while ORF2 encodes a ~150-kDa endo-
nuclease and reverse-transcriptase [12–15]. Both ORF1 and 
ORF2 are thought to preferentially interact with the same 
mRNA molecule from which they are translated, which 
generates a strong cis-preference for that encoding mRNA 
Fig. 1  Structure of the major 
mammalian retrotransposons. 
Mouse and human examples 
of the three different classes 
of mammalian retrotransposon 
(LINE, SINE, LTR) are shown. 
Transcription regulatory regions 
are indicated with filled rectan-
gles, and the main protein cod-
ing regions with open rectan-
gles. Transcriptional start sites 
are shown with an arrow. Some 
LTR retrotransposons, e.g. IAP, 
have lost the env gene present 
in their infectious progenitors 
[241]. LTR long terminal repeat
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to be retrotransposed [16]. LINe-1 elements are still retro-
transpositionally active in mammals, and spontaneous de 
novo integrations of LINe-1 elements have been reported 
to cause phenotypic changes and disease in both mice and 
humans [17–19].
SINe retrotransposons
Short interspersed nuclear element elements are non-auton-
omous retrotransposons that make up around 10 % of the 
sequenced mammalian genome [1, 2]. SINe elements are 
derived from a broad range of small cellular RNA poly-
merase III transcripts including 7SL RNA, 5S rRNA, and 
tRNAs, and rely on LINe-1-encoded proteins, particularly 
LINe-1 ORF2, to catalyse their retrotransposition [20–22]. 
SINe elements typically contain an internal RNA polymer-
ase III promoter and are therefore regulated quite differ-
ently from the LINe-1-encoded proteins that allow them to 
retrotranspose. The most prominent families of SINe ele-
ments in human and mouse genomes are the Alu and B1 
elements, respectively. Human Alu (~300 bp) and mouse 
B1 (~140 bp) elements are derived from the signal recogni-
tion particle 7SL cellular RNA, but subsequent re-arrange-
ments and duplications has led to these elements having 
quite different structures (Fig. 1) [23]. SINe elements 
can also be incorporated into cellular transcripts that run 
through their integration sites, which can provide a route 
for new variants of these elements to arise [24]. De novo 
insertions of SINe elements have been identified as poten-
tially causative mutations in both human and mouse genetic 
disease [17, 25]. even though SINe elements require 
LINe-1-encoded proteins for their mobilisation, the ger-
mline SINe retrotransposition rate in humans is estimated 
to be around five times higher than that of LINe-1 [17].
LTR retrotransposons
Long terminal repeat retrotransposons, also known as 
endogenous retroviruses (eRvs), have a typical retrovi-
ral structure with protein-coding gag, pol, pro and some-
times env genes flanked by long terminal repeats that act 
as promoters (Fig. 1) [26]. There are around 150 different 
types of eRv in a typical mammalian genome, classified 
into eRv1, eRvK, eRvL and MaLR families depending 
on their phylogenetic relationship. Like LINe-1 elements, 
LTR retrotransposons require the activity of the proteins 
that they encode in order to retrotranspose [27]. However, 
some LTR retrotransposons are non-autonomous and rely 
on proteins encoded by a different element to catalyse 
their retrotransposition [28]. LTR retrotransposons make 
up around 9 % of the human and mouse genomes; how-
ever, most of these LTR retrotransposons are lineage-spe-
cific elements that have arisen after the mouse and human 
lineages diverged from a common ancestor 65–75 million 
years ago [2]. Different types of LTR retrotransposon have 
been successful in colonising mouse and human genomes; 
eRvK elements are ten times more abundant in mouse than 
in human genomes, whereas human eRv1 elements are 
four times more abundant than their mouse counterparts 
[2]. with the possible exception of HeRvK (HML2) ele-
ments, the LTR retrotransposons that currently exist in the 
human genome do not appear to be retrotranspositionally 
active [26], and de novo insertions of LTR retrotransposons 
have not yet been identified as mutant alleles in human 
genetic disease [18]. In contrast, LTR retrotransposons are 
retrotranspositionally active in the mouse genome, and de 
novo insertions of eRv1, eRvK, eRvL and MaLR LTR 
retrotransposons have all been associated with spontaneous 
mutations in mice [18].
Retrotransposon expression in germ cells 
and pluripotent cells
For retrotransposons to be successful, they must be 
expressed and functional in developing germ cells, or in 
pluripotent cells, during the germline cycle (Fig. 2). De 
novo retrotransposition events in the germline cycle have 
been proposed to shape the genomic landscape through 
mediating chromosomal re-arrangements and by acting as a 
reservoir for the the emergence of new genes, in addition to 
providing a source of genetic variation within and between 
individuals [29, 30]. As the chromatin environment, tran-
scription factor availability and post-transcriptional regu-
lation of gene expression all vary significantly during the 
germline cycle, different retrotransposons have evolved 
to target different stages of germ cell development. The 
resulting variety of complex and dynamic retrotransposon 
expression patterns means that exaptation of retrotrans-
poson sequences can play a role in the evolution of gene 
expression networks at multiple points within the germline 
cycle [29, 31–33].
Retrotransposon expression in pre-implantation embryos
During pre-implantation development, the zygote under-
goes a series of mitotic divisions to generate a ball of 
pluripotent cells known as a morula (Fig. 2). The morula 
compacts and cavitates to generate a blastocyst possess-
ing trophectoderm, primitive endoderm and epiblast lay-
ers. The trophectoderm and primitive endoderm layers 
will give rise only to extra-embryonic structures, whereas 
the epiblast cells retain pluripotency and will give rise 
to all the tissues in the embryo, including the germ cells, 
after implantation (Fig. 2) [34]. Pre-implantation develop-
ment only takes around 4 days in mice, but shows dynamic 
J. H. Crichton et al.
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changes in retrotransposon expression. For example, RNA 
transcripts belonging to one of the most abundant LTR 
retrotransposons in the mouse genome, IAP elements, are 
present at high levels in fully-grown oocytes, decrease in 
1-cell embryos, then increase again during development 
to the blastocyst stage [32, 35, 36]. These IAP element 
transcripts are competent to generate A-type retroviral-
like particles, whose abundance follows similar dynam-
ics during these stages of development [36]. In contrast, 
epsilon-type retroviral-like particles, which are encoded by 
MueRvL eRvL LTR retrotransposons, are not present in 
fully-grown oocytes, transiently increase in abundance in 
2-cell embryos, then disappear as pre-implantation devel-
opment proceeds [36]. Again, the changes in epsilon-type 
retroviral-like particle abundance are mirrored by changes 
in abundance of MueRvL transcripts that encode these 
elements [32, 37]. The MT MaLR LTR retrotransposon 
transcripts exhibits yet another distinct expression pat-
tern during pre-implantation development and are highly 
abundant in mouse oocytes but sharply decrease in abun-
dance as pre-implantation development proceeds [32]. 
Thus, different types of retrotransposon have evolved to 
take advantage of the dynamic chromatin modifications 
and transcription factor profiles present at these stages of 
development. Interestingly, chimaeric transcripts originat-
ing from retrotransposon promoters but spliced onto host 
genes are present in oocytes and pre-implantation embryos 
[32], suggesting that mammalian hosts are co-opting retro-
transposons to drive gene expression during these stages of 
development.
IAP LTR retrotransposon expression during germ cell 
development
Germ cell development starts after implantation when the 
pluripotent epiblast differentiates into primordial germ 
cells in addition to the endoderm, mesoderm and ectoderm 
somatic tissues during gastrulation at e6.5–e7.5 (Fig. 2). 
The primordial germ cells proliferate and migrate to the 
genital ridges, colonising these structures around e10.5, 
and differentiate into meiotic oocytes or quiescent pros-
permatogonia by e13.5–e14.5 (Fig. 2). In males, the qui-
escent prospermatogonia can differentiate into spermatogo-
nial stem cells a few days after birth, which will give rise 
to cells progressing through spermatogenesis (proliferating 
spermatogonia → meiotic spermatocytes → post-meiotic 
spermatids → sperm) throughout the adult life of the ani-
mal (Fig. 2). In females, the oocytes that initiate meiosis in 
Fig. 2  Overview of the mouse 
germline cycle. Schematic over-
view of germ cell development 
in mice. Pluripotent cells are 
indicated in italicised text and 
germ cells in bold text. DNA is 
passed between germ cells and 
pluripotent cells through the 
generations in a germline cycle 
(green arrows). Differentiation 
into somatic tissues is indicated 
by grey arrows. The level of 
DNA methylation at different 
stages of development is indi-
cated by the level of shading
Regulation of germline genome defence
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the foetus undergo meiotic arrest a few days after birth, and 
groups of these arrested oocytes are selected to grow and 
mature during each oestrus cycle. Oocyte meiosis is not 
completed until the ovulated egg is fertilised to generate a 
zygote (Fig. 2) [4]. The advent of next generation sequenc-
ing technologies, and their application to analyse the tran-
scriptome of small numbers of cells, is likely to generate 
a wealth of data about genome-wide retrotransposon tran-
script levels at different stages of the germline cycle [38, 
39]. However, many stages of germ cell development have 
not yet been extensively analysed, and much of our under-
standing of retrotransposon expression during gametogen-
esis comes from studies on specific elements.
One of the best-studied LTR retrotransposons in mice 
is the IAP element. The IAP LTR drives transcription of 
a LacZ reporter preferentially in germ cells rather than 
somatic cells [40], and contains binding sites for a num-
ber of widely-expressed transcription factors, including 
YY1, SP1, CReB1 and glucocorticoid receptors [41]. 
Thus, the germline-specific expression of IAP elements 
does not appear to be caused by germ cell-specific tran-
scription factors. Rather, the preferential expression 
of IAP elements in the germline appears to be a conse-
quence of IAP element DNA being hypomethylated in 
germ cells, but methylated and silenced in somatic cells 
[42–45]. within the germline, IAP LTR-driven expression 
of a LacZ reporter is restricted to a fairly small window 
of germ cell development, with activity detectable in qui-
escent male foetal germ cells from e16, and in undiffer-
entiated spermatogonia in adult testes [40]. IAP DNA is 
hypomethylated at these stages [39, 40, 46–48]. Although 
the IAP LTR is sufficient to drive germline expression of 
a LacZ reporter, it does not recapitulate endogenous IAP 
transcription in adult liver [49] nor in pre-implantation 
embryos [32, 35, 36]. The liver IAP transcripts mainly 
originate from a single IAP locus suggesting that the local 
chromatin environment or cis-acting mutations allow this 
copy of IAP to be expressed in the liver [50]. In contrast, 
the endogenous IAP transcripts present in pre-implanta-
tion embryos arise from at least two different IAP sub-
types that have distinct expression patterns at these stages 
[35]. Sequences outside the LTR region might therefore 
be important for activating IAP expression in pre-implan-
tation embryos.
LINe-1 retrotransposon expression during germ cell 
development
The non-LTR LINe-1 retrotransposon has also been shown 
to be expressed at specific points in germ cell develop-
ment. LINe-1 RNA, protein, ribonucleoprotein particles 
and de novo retrotransposition events are all detectable 
in pluripotent stem cell lines, and LINe-1 expression is 
downregulated when these cells differentiate into somatic 
cells [51–53]. A number of widely-expressed transcription 
factors including RUNX3 and YY1 have been implicated 
in activating human and/or mouse LINe-1 transcription [8, 
54, 55]; however, more restricted transcription factors such 
as SOX2 could potentially confer some tissue and stage 
specificity [56]. LINe-1 RNA is also present in e11.5–
e13.5 primordial germ cells that have colonised the geni-
tal ridge [39, 57]. However, LINe-1 ORF1 protein is not 
detectable in the germ cells until e15.5, a stage of develop-
ment when male germ cells are quiescent and female germ 
cells are in leptotene/zygotene stages of meiotic prophase 
[58]. Interestingly, LINe-1 ORF1 protein levels decrease 
in germ cells after birth, but full-length LINe-1 transcripts 
and ORF1 protein peak again as male spermatocytes pass 
through the leptotene/zygotene stages of meiotic prophase 
[59]. Thus, early meiotic prophase may be a common point 
in male and female germline development for susceptibil-
ity to LINe-1 expression. LINe-1 ORF1 protein does not 
appear to be as abundant during later meiotic stages in 
either male or female germ cells [58, 59]. Interestingly, 
despite the high levels of LINe-1 expression during spe-
cific stages of male and female germline development, 
LINe-1 retrotransposition has been proposed to occur 
mainly in early pre-implantation embryos after fertilisation 
[60]. The poor correlation between LINe-1 RNA expres-
sion, LINe-1 protein expression and LINe-1 retrotranspo-
sition at some stages of the germline cycle could represent 
expression of non-functional full-length copies of LINe-1, 
or read-through transcription from adjacent host promot-
ers into non-functional 5′-truncated copies of LINe-1. In 
addition, genome defence mechanisms could be acting to 
inhibit different stages of the LINe-1 life cycle (Fig. 3) 
and dampen down the retrotransposition potential of these 
elements.
Retrotransposon activity in somatic tissues
Any de novo retrotransposition occurring in pluripo-
tent cells can potentially generate genetic variation in 
the somatic and germline components of an individual 
(Fig. 2). Somatic variation has been observed for de novo 
LINe-1 integration events in neurons, and this genetic het-
erogeneity has been proposed to be important for brain 
function [56, 61–63]. Although de novo LINe-1 integra-
tion events in neurons could arise from LINe-1 activity in 
pluripotent cells [60], LINe-1 expression within the neu-
ronal lineage [56] is also likely to contribute to this phe-
nomenon. Although successful retrotransposons need to 
be active in pluripotent cells or the developing germline, 
there is also some retrotransposon expression in somatic 
tissues. Analysis of LTR retrotransposon expression across 
multiple tissues using retrotransposon-specific microarrays 
J. H. Crichton et al.
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suggests that different LTR retrotransposons have differ-
ent somatic expression profiles [64, 65]. However, some of 
this somatic tissue-specific expression could represent the 
behaviour of a small number of anomalous copies of any 
particular retrotransposon, rather than an inherent tissue-
specificity of the LTR [50, 66]. One somatic tissue that 
has long been associated with retrotransposon expression 
is the placenta [67]. The trophectoderm-derived cells in 
the placenta have low levels of DNA methylation (Fig. 2), 
and their specialised epigenetic state is thought to make 
these cells permissive for expression of some retrotrans-
posons [68, 69]. Specific subsets of LTR retrotransposons, 
including eRvwe1 elements in human and IAP elements 
in mouse [64, 69], are highly expressed in the placenta, 
and retrotransposon-encoded proteins and LTRs have been 
co-opted to perform host functions during placenta devel-
opment [33, 70, 71]. Although retrotransposon expression 
or activity can be beneficial to the somatic tissues of their 
mammalian hosts, these elements have also been proposed 
to drive genetic instability and cancer [3, 19, 72]. estab-
lishing mitotically heritable suppression of retrotrans-
posons in the pluripotent cells early in development can 
therefore help to maintain genomic stability in the somatic 
tissues.
Epigenetic silencing of retrotransposons by DNA 
methylation
One of the major mechanisms that mammalian cells use to 
defend their genomes against retrotransposons is transcrip-
tional silencing (Fig. 3; Table 1). The main transcriptional 
silencing mechanisms known to be operating in mamma-
lian cells typically involve adding and removing covalent 
modifications to DNA and histones [73]. These modifica-
tions can alter chromatin structure, and change the physi-
cal associations between proteins and the underlying DNA 
sequence. One type of modification that is truly epigenetic, 
in that it can mediate heritable changes in gene activity 
without changing DNA sequence, is DNA methylation 
[74].
DNA methylation in mammalian genomes
In mammals, DNA methylation occurs almost exclusively 
on cytosine residues in the context of CpG dinucleotides 
[74]. Most of the mammalian genome, including repetitive 
DNA sequences, is heavily methylated [75, 76], but this 
bulk methylation is interrupted by short stretches of DNA 
containing high densities of CpGs known as CpG islands 
Fig. 3  Retrotransposon 
suppression mechanisms. 
A schematic overview of a 
generalised retrotransposon life 
cycle encompassing transcrip-
tion, RNA export, translation, 
assembly, nuclear import, and 
de novo integration is shown. 
Specific elements can show 
some variation in this process, 
e.g. RNA from non-autonomous 
SINe retrotransposons is not 
translated, and uses LINe-1-en-
coded proteins to catalyse their 
integration. Also, the mecha-
nism of integration differs 
between LINe-1 and LTR retro-
transposons. Genes involved in 
suppressing retrotransposons at 
specific stages of their life cycle 
in germ cells and pluripotent 
cells are indicated
Regulation of germline genome defence
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(CGIs) that escape DNA methylation [77]. The density of 
CpGs in the CGI affects the methylation status of these 
sequences, which are often found coincident with gene 
promoters. High density CpG CGI promoters are almost 
always unmethylated and transcriptionally active except 
in rare tissue-specific genes and some tumour suppres-
sor genes in cancer cells [75, 76, 78]. Intermediate density 
CpG CGI promoters are rarer than high density CpG CGI 
promoters but are more likely to be silenced and methyl-
ated in a tissue-specific manner [76]. In contrast, low CpG 
density CGIs promoters tend to be methylated irrespective 
of their transcriptional status [76]. The correlation between 
DNA methylation and transcriptional repression is there-
fore strongly influenced by CpG density and genomic 
context.
Adding DNA methylation to the genome
Mammals possess three DNA methyltransferases that 
can catalyse methylation of CpG dinucleotides: DNMT1, 
DNMT3A and DNMT3B. DNMT1 perpetuates exist-
ing DNA methylation marks by methylating hemi-meth-
ylated DNA templates [79–81]. DNMT1 is thought to be 
recruited to sites of DNA replication by its protein partner 
PCNA [82], where it uses the parental strand as a meth-
ylation template to modify the newly synthesised daugh-
ter strand, thereby maintaining DNA methylation patterns 
during proliferation. A second protein, Np95 (also known 
as UHRF1), helps recruit DNMT1 to hemi-methylated 
CpGs generated at the replication fork during DNA replica-
tion [83, 84]. Np95 binding to heterochromatin-associated 
histone modifications during DNA replication is essential 
for the recruitment of this maintenance methyltransferase 
complex; this ensures that DNMT1 activity is stabilised 
when in a complex with other heterochromatin-associated 
proteins during the late phase of DNA replication to per-
petuate a global methylation profile [84, 85]. During early 
development and gametogenesis, tissue-specific DNA 
methylation patterns are established in part by the two de 
novo DNA methyltransferases DNMT3A and DNMT3B 
[86]. Dnmt3a−/− Dnmt3b−/− double-knockout embryos 
have hypomethylated DNA, start to exhibit developmental 
retardation by e8.5, and die by e11.5 [86]. Interestingly, 
the de novo DNA methyltransferases have non-overlap-
ping roles at some genomic sequences: DNMT3B, but 
not DNMT3A, has a key role in regulating methylation at 
centromeric minor satellite repeats, and both interspersed 
C-type endogenous retroviruses (which includes MuLv 
eRv1 LTR retrotransposons) and IAP elements are slightly 
hypomethylated in Dnmt3b−/− embryos but retain methyla-
tion in Dnmt3a−/− embryos [86]. IAP hypomethylation is 
more pronounced in embryos lacking both DNMT3A and 
DNMT3B, suggesting a degree of redundancy between 
these two enzymes at these loci [86]. Detailed analysis 
of DNA methylation differences between these knockout 
embryos using current genome-wide approaches might 
provide some insight into the differences in specificity 
between the de novo DNA methyltransferases.
Like the Dnmt3a−/− Dnmt3b−/− double mutants, 
embryos that carry hypomorphic mutant alleles of Dnmt1 
become developmentally retarded soon after gastrula-
tion, and die by e12.5 [87]. Hypomethylation at IAP ele-
ments and C-type endogenous retroviruses, and increased 
expression of IAP retrotransposon transcripts, have all 
been shown to occur in these hypomorphic Dnmt1 mouse 
embryos [45, 87]. DNMT1 can act as a transcriptional 
repressor if it is recruited to unmethylated DNA by protein-
interacting partners, and DNA methylation-independent 
Table 1  Repression mechanisms affecting different types of retrotransposon in mouse eS cells and germ cells
Summary of some of the main mechanisms that have been shown to repress retrotransposons in mouse eS cells and germ cells. Different types 
of retrotransposon are repressed by different mechanisms, and are shown grouped by retrotransposon family
Retrotransposon 
family
Retrotransposon  
class
enriched chromatin  
modifications (eS cells)
Repression mechanisms  
(eS cells)
Repression mechanisms 
(germ cells)
LINe-1 LINe 5mC TRIM28, KDM1A DNA methyltransferases, 
PIwI-piRNA pathway, 
TDRD7
eRv1 LTR 5mC, H3K9Me3, H4K20Me3 TRIM28, SeTDB1, ZFP809, DNA 
methyltransferases, polycomb  
repressive complexes
Unknown
eRvK LTR 5mC, H3K9Me3, H4K20Me3 TRIM28, SeTDB1, HDAC1, DNA 
methyltransferases, polycomb  
repressive complexes
DNA methyltransferases, 
PIwI-piRNA pathway, 
LSH, TeX19.1, endog-
enous siRNA
eRvL LTR 5mC, H3K27Me3 TRIM28, KDM1A, ZFP42, RYBP Unknown
MaLR LTR 5mC, H3K27Me3 TRIM28 endogenous siRNA
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transcriptional repression by DNMT1 has been demon-
strated in frogs and mammals [88, 89]. However, devel-
opmental retardation, embryonic lethality and IAP and 
LINe-1 retrotransposon hypomethylation all occur in 
embryos that carry catalytically inactive mutant alleles of 
Dnmt1 [90], suggesting that these aspects of the Dnmt1 
mutant phenotype are a consequence of a failure to main-
tain DNA methylation.
Removing DNA methylation from the genome
The molecular pathways governing the removal of DNA 
methylation from mammalian genomes are also starting 
to be more fully realised, and the TeT family of dioxy-
genases are central to this process [91–94]. The TeT 
enzymes can iteratively oxidise 5mC to generate 5-hydrox-
ymethyl cytosine (5hmC), 5-formyl cytosine (5fC), and 
5-carboxyl cytosine (5caC) [95]. 5hmC, 5fC and 5caC are 
not maintained by DNMT1 during DNA replication, and 
can therefore lead to demethylation as they are diluted 
during cell proliferation [96, 97]. Alternatively, the DNA 
repair machinery can excise 5fC and 5caC, or deaminated 
derivatives of modified cytosine residues, to bring about 
demethylation [98, 99]. 5hmC is less abundant than 5mC 
in the genome and is typically enriched in the bodies of 
actively transcribed genes, and at active enhancers and 
sequences surrounding transcriptional start sites [100–
102]. The distribution of 5hmC across the genome is dis-
tinct between tissues, and 5hmC patterns can be used as an 
identifier of cell type or disease state [103, 104]. 5fC and 
5caC are even less abundant than 5hmC, and can also be 
detected at some enhancers and gene regulatory elements, 
particularly when components of the DNA repair machin-
ery are mutated to allow these transient intermediates to 
accumulate [105, 106].
Mammals possess three TeT enzymes. Tet1−/− and 
Tet2−/− mice each exhibit some phenotypic abnormalities, 
but these mice are viable and fertile [107–110]. In con-
trast, Tet3 is essential for viability and Tet3−/− mice die 
perinatally [111]. There is redundancy between TeT1 and 
TeT2 as Tet1−/− Tet2−/− double-knockout mice show some 
lethality at both embryonic and perinatal stages [112]. 
However, some Tet1−/− Tet2−/− double-knockout mice are 
viable and, aside from small ovaries, have no overt pheno-
typic abnormalities [112]. Tet1−/− Tet2−/− double-knockout 
mice have reduced levels of 5hmC and increased levels of 
5mC in somatic tissues, consistent with these genes hav-
ing a role in converting 5mC to 5hmC [112]. TeT enzymes 
play a role in reprogramming methylation patterns at some 
sequences during development, and are contributing to the 
general dynamic reprogramming of DNA methylation in 
the genome, which can possibly include retrotransposon 
sequences [105, 106, 110–113].
DNA methylation and transcriptional repression
DNA methylation is strongly enriched at retrotranspo-
son sequences in mammalian genomes, so much so that 
the primary role of DNA methylation has been proposed 
to be transcriptional repression of these elements [114]. 
DNA methylation could exert its repressive effects on 
transcription by sterically interfering with transcription 
factors binding to their cognate binding sites in promoter 
proximal regulatory regions [115]. Alternatively, a number 
of methyl-CpG-binding proteins have been identified in 
mammals that could influence transcription factor acces-
sibility or chromatin structure at genomic sites containing 
this epigenetic mark [116–119]. For example, the methyl-
CpG-binding protein MeCP2 is thought to mediate tran-
scriptional repression of methylated DNA at least partly 
through its interaction with the SIN3A co-repressor com-
plex [120]. It is not yet clear if methyl-CpG-binding pro-
teins are necessary for global silencing of methylated target 
genes or retrotransposons in mammalian cells [121]. How-
ever, the strong correlation between DNA methylation and 
transcriptional repression in the genome [76] primarily rep-
resents DNA methylation acting to ‘lock-down’ transcrip-
tion after a repressed state has already been established by 
other mechanisms, and only a small number of mammalian 
genes appear to rely on DNA methylation as a primary 
mechanism to silence their expression [43].
experimentally removing DNA methylation in mouse 
somatic tissues strongly induces expression of IAP retro-
transposons, suggesting that DNA methylation has a pri-
mary role in repressing these elements in mouse embryonic 
fibroblasts [42–44]. It is not clear how many other retro-
transposons rely predominantly on DNA methylation for 
their repression in somatic tissues. MMvL30 and MuLv 
elements, which are both members of the eRv1 family of 
LTR retrotransposons, are transcriptionally upregulated in 
response to DNA hypomethylation in mouse embryonic 
fibroblasts, suggesting that DNA methylation might be a 
primary transcriptional silencing mechanism for these ele-
ments [122]. However, recent data, showing that re-distri-
bution of polycomb-associated histone modifications is 
responsible for around a third of the transcriptional changes 
that occur in hypomethylated fibroblasts [123], illustrate 
the complex interactions that exist between different chro-
matin modifying mechanisms and the difficulties associ-
ated with interpreting these data mechanistically. Notably, 
both MMvL30 and MuLv elements are upregulated in 
eS cells carrying mutations in components of polycomb 
repressive complexes [124, 125].
Like the LTR retrotransposons, non-LTR LINe and 
SINe retrotransposons are also highly methylated in 
somatic tissues [126], but transcriptional silencing of these 
elements does not strongly depend on DNA methylation 
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in fibroblasts [122]. DNA methylation and MeCP2 have 
been implicated in repressing mouse and human LINe-1 
retrotransposons in neuronal cells [63]. However, MeCP2 
is a global regulator of neuronal chromatin structure, and 
the modest increase in retrotransposon expression seen in 
Mecp2−/− brains could reflect an increase in transcriptional 
noise [127].
Transcriptional silencing of retrotransposon expression 
in embryonic stem cells
Although a number of studies have reported that loss of 
DNA methylation causes strong upregulation of IAP ele-
ments in somatic tissues, eS cells carrying mutations in 
all three DNA methyltransferases exhibit a more modest 
upregulation of these elements, even though IAP DNA 
methylation is severely reduced [42–45, 125, 128–130]. 
Therefore, DNA methylation does not play as dominant a 
role in IAP suppression in eS cells as it does in somatic 
cells. Microarray and deep-sequencing analysis suggests 
that a relatively small number of LTR retrotransposons are 
upregulated in the hypomethylated Dnmt1−/− Dnmt3−/− 
Dnmt3b−/− triple-knockout (DnmtTKO) eS cells [125, 129]. 
Notably, LINe-1 elements and MuLv elements, which 
have been reported to be regulated by DNA methylation 
in neuronal and fibroblast somatic cell types, respectively 
[63, 122], are not strongly de-repressed in DnmtTKO eS 
cells despite being hypomethylated [129, 130]. In contrast, 
LTR retrotransposons belonging to eRv1 (MMeRGLN, 
RLTR1B) and eRvK (IAP, RLTR45, MMeRvK10C, 
RMeR16) families are all upregulated in DnmtTKO eS cells 
[129]. The level of upregulation for each of these elements 
(~2.3- to 13-fold) is relatively modest, suggesting that 
additional retrotransposon silencing mechanisms might be 
operating in eS cells.
An alternative repressive modification that is associ-
ated with retrotransposons in eS cells is histone 3 lysine 
9 trimethylation (H3K9Me3) [131]. H3K9Me3 is highly 
enriched on eRv1 and eRvK families of LTR retrotrans-
posons in eS cells, but not on the eRvL and MaLR fam-
ilies [131]. eS cells that carry mutations in the SeTDB1 
(also known as eSeT) histone methyltransferase have 
reduced levels of H3K9Me3 at LTR retrotransposon 
sequences, and a significant de-repression of many differ-
ent types of LTR retrotransposon [125, 129, 132]. In con-
trast to the DnmtTKO eS cells, 69 different LTR retrotrans-
posons are de-repressed in Setdb1−/− eS cells [129]. The 
upregulated LTR retrotransposons primarily belong to the 
eRv1 and eRvK families, whereas eRvL and LINe-1 
retrotransposons are not strongly upregulated in Setdb1−/− 
eS cells [129]. Interestingly, each LTR retrotransposon 
that is upregulated in DnmtTKO eS cells is more strongly 
upregulated in Setdb1−/− eS cells. Furthermore, the LTR 
retrotransposon upregulation in DnmtTKO eS cells is not 
associated with decreased levels of H3K9Me3 at these 
elements, and DNA methylation at these elements is not 
strongly affected in Setdb1−/− eS cells, suggesting that 
these silencing mechanisms are recruited independently, 
and function in parallel, to repress transcription of these 
elements [129]. Although H3K9Me3 is enriched on eRv1 
and eRvK LTR retrotransposons in fibroblasts, as it is in 
eS cells [131], a clear difference exists between these cell 
types in their requirement for SeTDB1 in this process. 
whereas SeTDB1 is bound to eRv1 and eRvK retrotrans-
posons and mediates H3K9Me3 and repression at these loci 
in eS cells, SeTDB1 is neither bound at these sequences 
nor required for their H3K9Me3 in fibroblasts [129, 132]. 
Thus, SeTDB1-dependent H3K9Me3 appears to play an 
important role in repressing eRv1 and eRvK retrotranspo-
sons in eS cells, but not in somatic fibroblasts.
Transcriptional silencing of the eRvL family of LTR 
retrotransposons in eS cells does not appear to depend 
on SeTDB1 [129], but relies instead on the histone dem-
ethylase KDM1A [133]. Kdm1a−/− eS cells de-repress 
MeRvL elements, LINe-1 elements and a number of chi-
maeric transcripts containing endogenous genes driven 
from eRvL and MaLR promoters similar to those found in 
zygotes [133]. eRvL and MaLR retrotransposon DNA is 
highly methylated in eS cells and somatic tissues [39, 126], 
but DNA methylation at these elements is not perturbed in 
Kdm1a−/− eS cells [133]. Rather, loss of KDM1A results 
in a number of changes to the histone modifications present 
at eRvL and MaLR LTRs in eS cells, with histone 3 lysine 
4 methylation (H3K4Me) and histone 3 lysine 27 acetyla-
tion (H3K27Ac) levels both increasing and H3K9Me3 lev-
els decreasing [133]. KDM1A physically interacts with the 
HDAC family of histone deacetylases, and the increase in 
H3K4Me and H3K27Ac levels at target retrotransposons 
in Kdm1a−/− eS cells might reflect reduced demethylase 
(KDM1A) and deacetylase (HDAC) activities, respectively, 
at these sequences [133]. eRvL and MaLR retrotrans-
posons are enriched for the polycomb-associated histone 
3 lysine 27 trimethylation (H3K27Me3) modification in 
wild-type eS cells [131], but H3K27Ac will prevent acqui-
sition of the repressive trimethyl modification at the same 
residue. eS cells carrying mutations in components of the 
polycomb repressive complexes de-repress various differ-
ent retrotransposons, including eRv1 (MuLv, MMvL30) 
and eRvK (IAP, RLTR45) LTR retrotransposons [124, 
125]. However, eRvL and MaLR LTR retrotransposons are 
not strongly de-repressed in these mutant eS cells, despite 
being strongly enriched for the H3K27Me3 mark [124, 
125, 131]. Thus, the de-repression of eRvL elements and 
MaLR sequences in Kdm1a−/− probably reflects multiple 
changes in histone modification and chromatin structure 
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at these sequences. The Kdm1a-dependent repression of 
eRvL and MaLR retrotransposons seems to be associated 
with the zinc finger protein ZFP42 (also known as ReX1). 
ZFP42 physically interacts with KDM1A and is bound to 
eRvL and MaLR retrotransposon DNA in eS cells [134]. 
Like Kdm1a−/− eS cells, Zfp42−/− eS cells also de-repress 
MeRvL retrotransposons [134]. Thus, ZFP42 could poten-
tially provide sequence specificity to this silencing mecha-
nism and recruit KDM1A to MeRvL and MaLR retro-
transposon DNA in order to transcriptionally repress these 
elements. RYBP, a protein that interacts with ZFP42, also 
plays a role in repressing MeRvL retrotransposons in eS 
cells [135].
Although there are differences in the mechanisms 
repressing the different LTR retrotransposon families 
(summarised in Table 1), one factor that has strong effects 
across the entire class of LTR retrotransposons is TRIM28 
(also known as KAP1). TRIM28 plays a role in silenc-
ing multiple LTR retrotransposons in eS cells including 
MuLv, IAP, MeRvL and MT elements belonging to each 
of the eRv1, eRvK, eRvL and MaLR families [136, 137]. 
Trim28−/− eS cells also modestly upregulate LINe-1 ret-
rotransposons [136]. TRIM28 can be recruited to specific 
DNA sequences via its interactions with Krüppel-associ-
ated box zinc finger proteins, and has been shown to inter-
act with repressive chromatin-modifying enzymes such as 
SeTDB1 and KDM1A [133, 138]. In eS cells, TRIM28 
is recruited to a specific sequence in MuLv retrotranspo-
sons by the zinc finger protein ZFP809 [137, 139]. The 
sequences responsible for TRIM28-dependent repression 
of MuLv are distinct from the sequences implicated in 
TRIM28-dependent repression of IAP elements, suggesting 
that different DNA-binding proteins are probably involved 
in recruiting TRIM28 to different retrotransposons [136]. 
Trim28−/− eS cells have reduced levels of H3K9Me3 at 
IAP elements, which presumably reflects impaired recruit-
ment of SeTDB1 to these loci, and upregulate IAP tran-
scription around 20-fold [129, 132, 136, 138]. Notably, 
DNA methylation at IAP elements is not strongly affected 
in Trim28−/− eS cells [136, 140], suggesting that TRIM28 
is silencing retrotransposons independently of DNA meth-
ylation in this cell type. Interestingly, the primary tran-
scriptional silencing mechanism for IAP retrotransposons 
appears to switch from being TRIM28/SeTDB1-depend-
ent histone modification in eS cells to DNA methylation 
in somatic cells [42, 43, 45, 128, 129, 132, 136]. Recent 
findings that differentiation of pluripotent Trim28−/− cells 
into somatic cells results in some reduction in the amount 
of DNA methylation at IAP retrotransposons suggests that 
there is a temporal link between TRIM28 and DNA methyl-
ation during differentiation and development [140]. These 
results are consistent with the concept that DNA methyla-
tion is generally recruited to chromatin after a repressed 
state has been established to stably repress transcription 
during somatic differentiation.
Transcriptional silencing of retrotransposons in the 
germline
Although a number of recent advances have been made in 
identifying transcriptional silencing mechanisms operat-
ing on retrotransposons in pluripotent cells, much less is 
known about the transcriptional regulation of these ele-
ments in developing germ cells (Table 1). DNA methyla-
tion and many histone modifications have been shown to 
undergo transient global decreases at multiple points in the 
germline cycle [141–144]. Genome-wide analysis of the 
sequences associated with specific histone modifications 
during germ cell development is starting to become techni-
cally possible [145], and it will be of interest to elucidate 
whether some of the transcriptional silencing mechanisms 
operating on retrotransposons in eS cells are also impor-
tant for retrotransposon silencing in germ cells. However, 
at present, the best-studied transcriptional silencing mecha-
nism operating at retrotransposon sequences in germ cells 
is DNA methylation.
DNA methylation in the developing germline
DNA methylation patterns undergo dynamic changes dur-
ing germ cell development (Fig. 2). The global level of 
DNA methylation in primordial germ cells decreases pro-
gressively between e8.5 and e12.5, although different 
sequences exhibit different dynamics during this process 
[39, 46, 146]. Genome-wide bisulfite sequencing shows 
that LINe retrotransposons, SINe retrotransposons and 
eRv1, eRvK, eRvL and MaLR LTR retrotransposons are 
all hypomethylated in e13.5 germ cells, and typically only 
have around 20 % of their CpG’s methylated compared to 
around 80 % in foetal somatic tissues [126]. Some LTR ret-
rotransposons, such as IAP elements, are more resistant to 
this hypomethylation event than others and still retain an 
intermediate amount of DNA methylation (~60 %) in e13.5 
germ cells [39, 147, 148]. Multiple intersecting pathways 
are likely to be involved in mediating this global demethyl-
ation, and conversion of 5mC to 5hmC by TeT1 and TeT2 
enzymes [113], deamination of 5mC by AID (also known 
as AICDA) [126], passive loss of cytosine modifications 
during DNA replication [39, 113, 149], active removal of 
nucleotides by the DNA repair machinery [150] and down-
regulation of DNA methyltransferases and their accessory 
factors [39, 46, 151] are all implicated in this process.
Once the germ cells have undergone global hypomethyl-
ation, DNA methylation patterns are re-established on ret-
rotransposon sequences in a sex-specific manner (Fig. 2). 
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Male germ cells undergo de novo methylation during late 
foetal and early postnatal development [152], long before 
male germ cells initiate meiosis. Genome-wide bisulfite 
sequencing shows that de novo methylation in the male ger-
mline generates sperm with similar, or even slightly higher, 
genome-wide and retrotransposon methylation levels to 
foetal somatic tissues [39]. In contrast, de novo methylation 
in female germ cells occurs in postnatal growing oocytes, 
after the oocytes have completed the early stages of mei-
otic prophase and are held in a dictyate stage meiotic arrest 
[153, 154]. De novo methylation increases the amount of 
DNA methylation in postnatal oocytes, but mature eggs 
remain hypomethylated relative to foetal somatic tissues 
and sperm [154, 155]. Although LINe, SINe, and LTR 
retrotransposons are all de novo methylated during oocyte 
growth, some copies of these retrotransposons remain par-
tially unmethylated in mature eggs [154, 155]. Acquisi-
tion of de novo methylation at some imprinted genes and 
intragenic CGIs in oocytes is associated with transcription 
through these regions [154, 156], but it is not clear whether 
this association extends to retrotransposons.
After fertilisation, DNA methylation declines during 
pre-implantation development (Fig. 2), with LINe, SINe 
and LTR retrotransposon sequences all losing DNA meth-
ylation [155, 157, 158]. Some retrotransposons, including 
IAP elements, are somewhat resistant to this hypomethyla-
tion event [148, 158]. At the blastocyst stage of pre-implan-
tation development, DNA methylation levels increase in the 
pluripotent epiblast cells [157], and genome-wide bisulfite 
sequencing of eS cells derived from this tissue shows that 
global and retrotransposon DNA methylation levels are 
similar between eS cells, post-implantation epiblast, and 
foetal somatic tissues [39, 126]. In contrast, DNA meth-
ylation levels remain low in the trophectoderm layer of 
the blastocyst [157], and the placenta has moderate levels 
of methylation (~40–50 %) at LINe, SINe and LTR retro-
transposon sequences [126], representing a mixed popula-
tion of hypomethylated trophectoderm-derived and hyper-
methylated epiblast-derived tissues.
De novo DNA methylation of retrotransposon sequences 
during gametogenesis
Mutations that interfere with de novo DNA methylation 
might be expected to cause defects in epigenetic repro-
gramming and retrotransposon silencing in the develop-
ing germline. The lethality of Dnmt3a−/− and Dnmt3b−/− 
embryos has necessitated the generation of conditional 
mutants to investigate the function of these genes in the 
germline [159]. Dnmt3a−/− and Dnmt3b−/− prospermato-
gonia have normal DNA methylation levels at IAP and 
LINe-1 elements, possibly indicating functional redun-
dancy between DNMT3A and DNMT3B at these loci [152, 
159, 160]. In contrast, de novo methylation of B1 SINe ret-
rotransposons in spermatogonia requires DNMT3A but not 
DNMT3B [152]. In oocytes, there is redundancy between 
DNMT3A and DNMT3B for de novo DNA methylation at 
IAP elements, but only DNMT3A is involved in de novo 
DNA methylation of LINe-1 elements [161]. Thus, the de 
novo methyltransferases have different specificities for ret-
rotransposon sequences.
The de novo methyltransferase activity of both 
DNMT3A and DNMT3B is stimulated by the catalytically 
inactive DNA methyltransferase-like protein DNMT3L 
[162]. In contrast to Dnmt3a and Dnmt3b, Dnmt3l is not 
required for viability or retrotransposon DNA methylation 
in somatic tissues. However, Dnmt3l−/− mice are infertile 
and have defects in de novo methylation during spermato-
genesis and oogenesis [152, 163–166]. Dnmt3l−/− prosper-
matogonia and oocytes have reduced levels of DNA meth-
ylation at LINe-1, IAP and B1 SINe retrotransposons [152, 
154, 155, 161, 163, 166]. The hypomethylation at IAP and 
LINe-1 retrotransposons in Dnmt3l−/− prospermatogonia is 
associated with transcriptional activation of these elements 
in foetal and perinatal testes [163]. De novo methylation of 
IAP and LINe-1 retrotransposons in foetal male germ cells 
therefore seems to be required for transcriptional silencing 
of these elements in the prospermatogonia.
Another factor that has been linked with de novo DNA 
methylation of retrotransposons sequences and genome 
defence is LSH (also known as HeLLS). LSH is not 
restricted to the germline and is required for normal embry-
onic DNA methylation of repetitive elements and some 
single copy genes in somatic tissues [167, 168]. LSH has 
been proposed to recruit the de novo DNA methyltrans-
ferase DNMT3B to specific target sites in the genome 
[169]. Notably, loss of LSH function is sufficient to de-
repress IAP transcription in mouse embryonic fibroblasts, 
alter pericentromeric heterochromatin, and induce gene 
expression changes at single copy genes [170, 171]. The 
DNA hypomethylation at IAP elements that occurs in 
Lsh−/− somatic tissue is also evident in Lsh−/− oocytes, 
and IAP expression is greatly increased in Lsh−/− foetal 
ovaries [172]. As IAP is normally hypomethylated in mei-
otic oocytes until the postnatal oocyte growth phase [153], 
either the IAP hypomethylation in Lsh−/− oocytes is affect-
ing a subset of CpGs critical for transcriptional repression 
of these elements, or the transcriptional upregulation of 
IAP in Lsh−/− ovaries is a feature of the somatic cells in 
the ovary rather than oocytes. The role of Lsh in de novo 
DNA methylation in foetal prospermatogonia and growing 
oocytes has not yet been studied, and it will be of interest to 
determine whether de novo methylation events occurring at 
different stages of the germline cycle (Fig. 2) have different 
requirements to direct the DNA methylation machinery to 
target loci.
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PIwI proteins and retrotransposon DNA methylation
A number of additional genes are also required for de novo 
methylation and transcriptional silencing of retrotranspo-
sons in male germ cells. PIwI proteins belong to a subclade 
of the Argonaute family of small RNA binding proteins 
and contain RNA binding and RNaseH-like endonuclease 
domains [173]. Mice possess three PIwI proteins: MIwI 
(also known as PIwIL1), MILI (also known as PIwIL2), 
and MIwI2 (also known as PIwIL4), that each physically 
interact with populations of germline-restricted small, sin-
gle-stranded RNAs known as PIwI-interacting RNAs (piR-
NAs) [174–178]. expression of the three PIwI proteins is 
largely restricted to the germline, but each PIwI protein 
has a different expression pattern during germ cell develop-
ment (Fig. 4). Mili and Miwi2 are expressed in late foetal 
male germ cells when de novo methylation of retrotrans-
poson DNA occurs [176, 178]. Mili−/− and Miwi2−/− pros-
permatogonia fail to de novo methylate IAP and LINe-1 
elements, and de-repress transcription of these elements 
[47, 175–177]. It is not clear whether the methylation state 
of other retrotransposons is affected in these mutant germ 
cells, and genome-wide analysis of their DNA methylation 
patterns would be of interest in this regard.
Although Mili and Miwi2 are required genetically for the 
de novo methylation of retrotransposons [47, 175–177], the 
mechanistic role that PIwI proteins play in this process is 
not fully understood. MILI and MIwI2 physically interact 
with piRNAs that originate from genomic piRNA clusters, 
retrotransposons and other genomic regions [47, 175, 176]. 
Ping-pong amplification of piRNA sequences occurs when 
an antisense piRNAs guides the cleavage of a complemen-
tary mRNA to generate sense piRNAs, which in turn can 
guide cleavage of complementary sequences in piRNA 
cluster transcripts to generate more antisense piRNAs 
to feed back into the system. Molecular chaperones are 
thought to be important to dissociate PIwI-piRNA com-
plexes, allowing ping-pong amplification to occur [179]. 
MILI and MIwI2 physically associate with different sub-
populations of piRNA in foetal prospermatogonia, and have 
different roles in de novo methylation of retrotransposon 
sequences [47, 176]. The putative endonuclease activity of 
MILI appears to be required for ping-pong amplification of 
retrotransposon piRNAs in foetal prospermatogonia, and de 
novo methylation and transcriptional silencing of LINe-1, 
but not IAP elements [180]. In contrast, the putative endo-
nuclease activity of MIwI2 is not required for these events 
[180], and MIwI2 has been proposed to function by trans-
locating into the nucleus when loaded with piRNA, where 
it uses the piRNA sequence as a guide to recruit the de 
novo methylation machinery to actively transcribing retro-
transposons [176]. However, physical interactions between 
MIwI2 and either DNMT3A or DNMT3B have not been 
detected in foetal prospermatogonia [176]. It is possible 
that the MIwI2/piRNA complexes recruit the de novo DNA 
methylation machinery indirectly, perhaps through induc-
ing repressive histone modifications at retrotransposon loci. 
However, although there is strong genetic evidence that 
Fig. 4  expression patterns and 
mutant phenotypes of germline 
genome defence genes. The 
stages of spermatogenesis are 
indicated along the top of the 
diagram, and expression pat-
terns of the indicated germline 
genome defence genes are 
indicated by blue bars. The 
stages at which mutant mice are 
reported to have defects in pro-
gression through spermatogen-
esis are indicated with crosses
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Mili and Miwi2 are required for de novo DNA methylation 
of LINe-1 and IAP retrotransposons in male germ cells, 
the requirement for piRNA in this phenomenon is yet to be 
formally demonstrated. In this respect, it is notable that the 
third mouse PIwI protein, MIwI, has recently been shown 
to have some piRNA-independent functions in regulating 
gene expression [181].
De novo methylation of retrotransposons in foetal pros-
permatogonia also requires a number of additional factors 
that act in the PIwI–piRNA pathway. Tudor domain-con-
taining proteins physically interact with methylated argi-
nine residues in PIwI proteins [182–184], and co-localise 
with PIwI proteins and piRNAs in electron-dense cyto-
plasmic structures termed nuage [185–188]. The forma-
tion of these structures and interactions between them are 
thought to be crucial for the biogenesis of piRNAs and 
functional piRNA–PIwI complexes, and TDRD1, TDRD5 
and TDRD9 are all required for normal DNA methylation 
of LINe-1 retrotransposons [186, 187, 189]. Tdrd1−/−, 
Tdrd5−/− and Tdrd9−/− mutations all have stronger effects 
on transcriptional silencing of LINe-1 than IAP retrotrans-
posons [186, 187, 189], again suggesting that there are dif-
ferences in the requirements for de novo methylation of 
these elements.
Additional nuage-associated factors, including MITO-
PLD (also known as PLD6), MOv10L1, MvH (also known 
as DDX4), MAeL, and ASZ1 (also known as GASZ) 
are all required for DNA methylation and transcriptional 
silencing of LINe-1 retrotransposons through their involve-
ment in the piRNA–PIwI pathway [190–194]. MITOPLD 
and MOv10L1 appear to be required for piRNA biogenesis 
[192, 193], and MvH is reported to be involved in piRNA 
processing [194]. MAeL does not appear to be required 
for piRNA biogenesis, but is speculated to play a role in 
assembly of PIwI–piRNA complexes or shuttling PIwI–
piRNA complexes to or from the nuage [191], whereas 
ASZ1 is required to stabilise MILI [190].
Although each of the three mouse PIwI proteins is 
expressed in male germ cells and required for spermato-
genesis, only MILI is expressed in the female germline 
[176–178, 195, 196]. MILI is not required for oogenesis 
but does appear to play a role in retrotransposon suppres-
sion in oocytes [197]. The levels of IAP transcript are mod-
estly upregulated 3.5-fold in Mili−/− oocytes, but, in con-
trast to Mili−/− male germ cells, LINe-1 transcript levels 
are not affected. The level of IAP upregulation in Mili−/− 
oocytes is around 10-fold lower than the level of upregula-
tion in Mili−/− testes [175], and it remains to be determined 
if the increase in IAP expression in Mili−/− mutant oocytes 
is due to defects in de novo methylation at these elements, 
or is a result of MILI’s proposed additional roles in post-
transcriptional regulation [47, 198].
Post‑transcriptional suppression of retrotransposon 
RNAs in the germline
There is some evidence that retrotransposon RNAs can 
be suppressed at a post-transcriptional level in germ cells 
(Fig. 3). The putative endonuclease activity of PIwI pro-
teins could potentially allow PIwI–piRNA complexes 
to destabilise retrotransposon RNAs via endonucleolytic 
cleavage. This ‘slicer’ activity towards retrotransposon 
mRNAs has recently been demonstrated for MIwI [199]. 
MIwI is expressed postnatally from the zygotene stage 
of meiosis until the haploid round spermatid stage [195], 
although the piRNA populations in post-pachytene male 
germ cells show little evidence of ping-pong amplifica-
tion [181, 200]. MIwI-associated piRNAs are able to guide 
MIwI to cleave target RNAs with extensive complementa-
rity [199]. LINe-1 RNA is a target for MIwI slicer activ-
ity and LINe-1 transcript levels are increased ~10-fold in 
round spermatids carrying a catalytically inactive allele of 
Miwi that lacks endonuclease activity [199]. LINe-1 DNA 
methylation and repeat-derived piRNA abundance are not 
altered in the Miwi endonuclease mutant round spermatids; 
however, the likely post-transcriptional increase in LINe-1 
transcripts in these mutants could represent a combination 
of piRNA-dependent and piRNA-independent functions of 
MIwI [199, 201]. It is not clear if MIwI’s slicer activity is 
also important for post-transcriptional suppression of other 
types of retrotransposon, but this activity is likely to act as 
a back-up genome defence mechanism to target LINe-1 
retrotransposons that have escaped suppression by tran-
scriptional silencing mechanisms.
Post-transcriptional suppression of retrotransposons also 
occurs in female germ cells. endogenous double-stranded 
small interfering RNAs (siRNAs) are present in oocytes, 
where they play a role in post-transcriptional silencing 
of retrotransposons [197, 202, 203]. Production of these 
endogenous siRNAs requires DICeR1, an endoribonu-
clease that is expressed at high levels throughout oocyte 
growth [197]. The endogenous siRNAs in oocytes physi-
cally associate with AGO2 [197], an Argonaute protein that 
forms the catalytic component of the RNA-induced silenc-
ing complex [204]. Members of the eRvK and MaLR fam-
ilies of LTR retrotransposons (RLTR10 and MTA elements, 
respectively) are upregulated ~3- to 5-fold in Dicer1−/− 
and Ago2−/− growing oocytes, but LINe-1 and IAP tran-
script abundance does not change [197, 203]. Interestingly, 
whereas Dicer1/Ago2 suppress MTA and RLTR10 but not 
IAP retrotransposons in growing oocytes, Mili suppresses 
IAP but not MTA or RLTR10 retrotransposons in these 
cells [197]. Thus, the Mili/piRNA and Dicer1/Ago2/endog-
enous siRNA pathways are associated with silencing differ-
ent retrotransposons in growing oocytes.
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Interestingly, LINe-1 expression in growing oocytes is 
not affected by any of the Mili−/−, Dicer1−/− or Ago2−/− 
mutations [197]. However, post-transcriptional silencing 
of LINe-1 retrotransposons in the fully-grown oocytes 
depends on the putative RNA-binding protein MARF1 
[205]. Marf1−/− oocytes exhibit numerous changes in 
mRNA abundance, including an upregulation in the levels 
of LINe-1 and IAP transcripts, despite there being no sig-
nificant changes in IAP or LINe-1 DNA methylation [205]. 
It will be of interest to determine whether MARF1 directly 
interacts with LINe-1, IAP and any other retrotransposon 
mRNA in oocytes, and how any sequence specificity is 
determined.
Other mechanisms of retrotransposon suppression
Although germ cells possess multiple mechanisms to 
prevent the accumulation of retrotransposon transcripts 
(Fig. 3), retrotransposon RNAs are readily detectable and 
even abundant in germ cells and pluripotent cells in wild-
type mice. Furthermore, discrepancies between full-length 
retrotransposon transcript abundance, protein abundance, 
and retrotransposition activity at different stages of the ger-
mline cycle suggest that additional mechanisms that sup-
press retrotransposons at later stages of their life cycles 
are operating in the germline [32, 35, 38, 40, 52, 59, 60]. 
The Tudor domain-containing protein TDRD7 plays a role 
in translational regulation of LINe-1 retrotransposons in 
male germ cells [206], and two of the PIwI proteins, MILI 
and MIwI, physically associate with actively translating 
mRNAs in polysomes and are implicated in translational 
regulation [198, 207]. Interestingly, some piRNAs are also 
physically associated with polysomes in mouse testes [207]. 
It is not known whether retrotransposon mRNAs are targets 
for translational regulation by MILI or MIwI, but there is 
evidence that piRNAs can suppress translation of LINe-1 
mRNAs. Deletion of a genomic cluster of piRNAs (Nct1/2) 
that includes an antisense LINe-1 sequence results in a 
modest ~1.5-fold increase in LINe-1 mRNA, but a striking 
~15-fold increase in levels of LINe-1-encoded ORF1 pro-
tein [208]. piRNA-containing protein complexes could sup-
press LINe-1 translation in a similar way that microRNAs 
suppress translation of their target mRNAs [204].
Genome defence mechanisms operating at even later 
stages of the retroviral life cycle have been demonstrated 
in somatic tissues. MOv10, a putative RNA helicase, 
physically associates with human LINe-1 ribonucleopro-
tein particles and mouse IAP retroviral-like particles, and 
inhibits retrotransposition of both these elements in cellu-
lar assays, and can affect multiple stages of the retroviral 
life cycle [209–211]. Interestingly, germ cells express a 
paralog of the somatic Mov10 gene, Mov10l1. MOv10L1 
physically interacts with MILI, MIwI2 and MIwI proteins, 
and Mov10l1−/− testes have reduced amounts of piRNA, 
hypomethylation of LINe-1 DNA and de-repression of 
LINe-1 and IAP elements [193, 212]. Conditional dele-
tion of Mov10l1 from the pachytene stage of spermato-
genesis onwards reveals that MOv10L1 has additional 
functions in late spermatogenesis [201]. Mov10l1−/− 
round spermatids display elevated DNA damage, which 
could indicate increased retrotransposition in these cells. 
Although LINe-1 and IAP RNA levels are not elevated in 
Mov10l1−/− round spermatids [201], MOv10L1 could, like 
its somatic paralog, be suppressing LINe-1 and IAP activ-
ity at later stages of the retrotransposon life cycle.
Another protein that is operating to repress retrotrans-
posons in the developing germline is TeX19.1, a pre-
dominantly cytoplasmic protein in germ cells and pluri-
potent cells that represses the eRvK LTR retrotransposon 
MMeRvK10C in postnatal testes [213]. Unlike a number 
of genes implicated in germline genome defence, Tex19.1 
does not appear to have a strong effect on endogenous gene 
expression, and the largest changes in gene expression in 
Tex19.1−/− testes are retrotransposon transcripts [125, 213]. 
LINe-1, B1 SINe and IAP retrotransposons are not upreg-
ulated in Tex19.1−/− knockout testes, and microarray analy-
sis suggests that retrotransposon upregulation in Tex19.1−/− 
testes is primarily restricted to MMeRvK10C [125, 213]. 
The exact molecular mechanisms of how TeX19.1 sup-
presses accumulation of MMeRvK10C transcripts is not 
yet known, but studies on the role of Tex19.1 in somatic 
placenta tissue illustrate one of the complexities in deter-
mining retrotransposon targets for genome defence mecha-
nisms: in contrast to Tex19.1−/− testes, multiple retrotrans-
posons including MMvL30 LTR retrotransposons and 
LINe-1 elements are upregulated in Tex19.1−/− placenta 
[69]. The presence of multiple complementary genome 
defence mechanisms in the developing germline is likely to 
be masking some of the effects of mutating individual ret-
rotransposon suppression mechanisms in these cells.
Regulation of germline genome defence genes by DNA 
methylation
A number of genes involved in suppressing retrotrans-
posons in the germline have been shown to be regulated 
by DNA methylation. Dazl, Zfp42, Mvh and Mael have 
all been identified as belonging to groups of genes that 
require Dnmt3b-dependent promoter DNA methylation to 
silence their expression [214, 215]. Furthermore, analy-
sis of gene expression changes in multiple somatic cell 
models for hypomethylation identified a core subset of 
26 methylation-sensitive genes, which is highly enriched 
for genes involved in suppressing retrotransposons in the 
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germline [43]. This group of methylation-sensitive ger-
mline genome defence genes, which includes Tex19.1, Mili, 
Dazl, Asz1 and Mov10l1, is strongly and heritably upregu-
lated in response to DNA hypomethylation [43]. Interest-
ingly, methylation-sensitive germline genome defence gene 
promoters are not enriched for commonly studied repres-
sive histone modifications, such as H3K27Me3, H3K9Me3 
and histone 4 lysine 20 trimethylation (H4K20Me3), when 
they are transcriptionally repressed in somatic cells [43]. 
The lack of enrichment for these repressive histone modi-
fications could explain why silencing of these genes is so 
dependent on DNA methylation.
During germline development, expression of the meth-
ylation-sensitive germline genome defence genes is initi-
ated during the global wave of demethylation that occurs 
progressively in primordial germ cells between e8.5 and 
e12.5 (Fig. 4) [43, 46, 146]. Hypomethylation and expres-
sion of Tex19.1 and Mili initiates early during this repro-
gramming event at ~e8.5–e9.5 while the primordial germ 
cells are migrating [43]. Hypomethylation and initiation of 
Dazl, Mov10l1 and Asz1 expression occurs towards the end 
of this epigenetic reprogramming event at ~e10.5–e11.5, 
after the germ cells have colonised the gonad [43, 216]. It 
is not known whether the differences in the timing of hypo-
methylation at different germline genome defence gene 
promoters reflect recruitment of different demethylation 
machineries to these genes [98]. Generally, expression of 
the germline genome defence genes is maintained through-
out foetal germ cell development (Fig. 4) and in oocytes 
in adult females. In males, postnatal expression of the ger-
mline genome defence genes starts to decline in pachytene 
spermatocytes (Tex19.1, Mili and Dazl) and in round sper-
matids (Asz1 and Mov10l1) (Fig. 4) [43, 176, 178, 190, 
193, 217–219]. It is not clear whether DNA methylation 
transcriptionally represses these genes in these later stages 
of spermatogenesis.
Global DNA hypomethylation in the primordial germ 
cells extends to retrotransposon sequences [39, 126, 147, 
148], and removing this extra layer of repression could 
potentially lead to variant copies of these elements being 
transcribed. The activation of IAP LTR transgenes in male 
foetal germ cells from ~e16 [40] is consistent with the 
hypothesis that at least some copies of these methylation-
sensitive retrotransposons are becoming transcriptionally 
de-repressed in hypomethylated germ cells. Indeed, it is 
possible that some transcriptional de-repression of retro-
transposons is a pre-requisite for the generation of piRNA, 
and PIwI–piRNA-mediated targeting of de novo meth-
ylation to retrotransposon sequences [176]. Notably, ger-
mline genome defence genes that act at post-transcriptional 
stages of the retrotransposon life cycle (Fig. 3) could play 
an important role in limiting retrotransposon activity dur-
ing these periods of global hypomethylation. Coupling 
expression of post-transcriptional genome defence mecha-
nisms to the initiation of this epigenetic reprogramming 
process provides an effective way to ensure that appropriate 
genome defence mechanisms are active during the develop-
mental window when the potential for retrotransposons to 
become active is high.
Hypomethylated cells in the mammalian placenta 
(Fig. 2) are another potential site for transcriptional de-
repression of retrotransposons and activation of methyla-
tion-sensitive germline genome defence genes. Retrotrans-
posons are hypomethylated in the placenta [68, 126, 220], 
but Tex19.1 is the only one of the germline genome defence 
genes to be strongly hypomethylated and expressed at 
similar levels in the placenta and the testis [69]. LINe-1 
retrotransposons are upregulated in the hypomethylated 
trophectoderm-derived component of Tex19.1−/− placen-
tas, suggesting that this germline genome defence gene is 
functionally repressing retrotransposons in this hypometh-
ylated somatic context [69]. Although the germline genome 
defence genes are normally methylated and silenced in 
embryo-derived somatic tissues, expression of this group 
of genes can be induced in somatic contexts in response 
to environmental or toxicological insults that perturb DNA 
methylation. widespread changes in DNA methylation 
have been reported to occur in numerous cancers [221, 
222], and genetic instability caused by retrotransposon 
activity can drive tumourigenesis [19]. The potential func-
tional roles of the germline genome defence genes in hypo-
methylated somatic contexts is clearly an exciting area that 
requires further investigation.
Consequences of failures in genome defence
Defects in germline genome defence might be expected 
to result in increased rates of retrotransposition, and new 
retrotransposon integrations being passed on to the next 
generation. However, mutations in most of the germline 
genome defence genes result in male infertility, making it 
difficult to assess de novo retrotransposition rates in their 
offspring. Curiously, many of the germline genome defence 
mutants have strong phenotypic similarities and common 
arrest points in spermatogenesis (Fig. 4). De-repression 
of retrotransposons might therefore have additional and 
more immediate consequences for germ cell development 
than generating new retrotransposition events in the next 
generation.
Consequences of mutations in the DNA methylation 
machinery
At a cellular level, Dnmt3l−/− mice display defective sper-
matogonial proliferation, delayed entry into meiosis and 
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arrested meiotic progression at pachytene in young adults. 
Older mutant adults become completely azoospermic due 
to progressive loss of spermatogonia, suggesting defects 
in the maintenance of spermatogonial stem cells [163, 
223]. Although Dnmt3l−/− mutant prospermatogonia have 
defects in DNA methylation of multiple genomic features 
[152, 163], it is not clear how DNA hypomethylation 
causes the spermatogonial stem cell or meiotic phenotypes 
in these mice.
Impaired maintenance of spermatogonial stem cells and 
delayed entry into meiosis also occur in Dnmt3a−/− germ 
cells, whereas Dnmt3b−/− germ cells have no severe dis-
ruptions in spermatogenesis and are able to form func-
tional sperm [159, 160]. Thus, methylation at DNMT3A-
specific targets such as B1 SINe retrotransposons or some 
imprinted genes might be important for spermatogonial 
stem cell maintenance and timing of meiotic entry, but 
hypomethylation at DNMT3B-specific targets such as sat-
ellite sequences [152] does not disrupt spermatogenesis. 
Notably, the meiotic arrest seen in Dnmt3l−/− testes is not 
recapitulated in either the Dnmt3a−/− or Dnmt3b−/− single-
knockout male germ cells [159, 160]. Thus, hypometh-
ylation at redundant genomic targets of DNMT3A and 
DNMT3B, such as LINe-1 retrotransposons, IAP retro-
transposons or some imprinted genes [152], are likely to be 
responsible for the meiotic defects in Dnmt3l−/− testes.
The meiotic arrest evident in Dnmt3l−/− spermato-
cytes is characterised by defective synaptonemal complex 
formation, with widespread chromosome asynapsis and 
non-homologous synapsis [163]. Recombination proteins 
RAD51 and RPA1 localise to chromosome axis-associated 
foci at a similar frequency in wild-type and Dnmt3l−/− 
spermatocytes [224], indicating that the chromosome syn-
apsis defect is not a downstream consequence of a failure 
to initiate meiotic recombination. The presence of asyn-
apsed chromosomes in Dnmt3l−/− pachytene spermato-
cytes sequesters the transcriptional silencing machinery, 
impairing meiotic sex chromosome inactivation and lead-
ing to spermatocyte apoptosis [224]. The meiotic arrest in 
Dnmt3l−/− testes is perhaps surprising given that expres-
sion of Dnmt3l is so low during meiosis [223], and presum-
ably reflects defects in de novo methylation that arise ear-
lier in the foetal prospermatogonia.
Although Dnmt3l−/− male mice have numerous cellular 
defects in spermatogenesis, meiosis and oogenesis proceed 
normally in females, notwithstanding the failure in mater-
nal imprinting [164, 165]. The differential requirement for 
DNMT3L in meiotic chromosome synapsis between males 
and females likely reflects de novo methylation occurring 
before the initiation of meiosis in males, but after meiotic 
chromosome synapsis is complete in females [152, 153]. 
Oocytes therefore have low levels of genomic DNA meth-
ylation while they progress through the early stages of 
meiotic prophase [39]. The low level of DNA methylation 
that is present in meiotic oocytes appears to be required 
for normal chromosome synapsis and progression through 
meiosis. Lsh−/− oocytes have reduced levels of DNA meth-
ylation, and, although these oocytes initiate meiotic recom-
bination normally, they fail to synapse their homologous 
chromosomes properly [172]. The meiotic defects in hypo-
methylated Lsh−/− oocytes bear some similarity to those in 
hypomethylated Dnmt3l−/− spermatocytes [163, 172, 224]. 
Thus, even though there are sex-specific differences in the 
mechanisms that generate the correct DNA methylation 
patterns for meiosis, reducing DNA methylation has simi-
lar consequences for meiotic chromosome synapsis in both 
spermatocytes and oocytes.
Consequences of mutations in the PIwI–piRNA system
The PIwI–piRNA pathway acts genetically upstream of 
Dnmt3l-dependent de novo DNA methylation, and there-
fore many of the genome defence genes that are impor-
tant for PIwI–piRNA function in foetal prospermatogonia 
share cellular spermatogenic defects with Dnmt3l−/− mice. 
Like Dnmt3l−/− testes, self-renewal/maintenance of sper-
matogonial stem populations are reduced in Mili−/− testes 
and in Miwi2−/− testes [177, 198]. The male germ cells 
that progress to meiosis in Miwi2−/− testes are able to ini-
tiate meiotic recombination, but chromosome synapsis is 
severely defective in these cells [177]. Interestingly, these 
meiotic defects arise some time after Miwi2 is expressed 
during spermatogenesis (Fig. 4), suggesting that defects in 
Miwi2−/− prospermatogonia are being heritably transmit-
ted through multiple rounds of mitosis. Mili−/− spermato-
cytes also fail to progress through pachytene, although the 
precise nature of the meiotic defects in these cells has not 
been determined [196]. At least some Mili−/− single-knock-
out and Mili−/− Miwi−/− double-knockout spermatocytes 
appear to successfully synapse their chromosomes, and 
progress further into pachytene than Miwi2−/− spermato-
cytes [177, 196, 225]. As MILI is required for localisation 
of MIwI2 to cytoplasmic granules and accumulation of the 
MIwI2-interacting piRNA population [176], it is not clear 
whether the apparent differences between the Mili−/− and 
Miwi2−/− meiotic phenotypes reflect complex interactions 
between these PIwI proteins during meiosis, or differ-
ences in the phenotypic analyses. Taken together, these data 
suggest that the PIwI–piRNA pathway and de novo DNA 
methylation in foetal prospermatogonia facilitate chromo-
some synapsis and progression through pachytene in post-
natal meiotic spermatocytes.
Male mice with mutations in other genes required for 
piRNA biogenesis or PIwI–piRNA function, including 
Mov10l1, Asz1, Mvh and Mitopld, all have defects in pro-
gression through the zygotene/pachytene stages of meiotic 
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prophase where chromosome synapsis occurs [190, 192, 
193, 212, 226]. where studied, chromosome synapsis is 
defective in these mutant spermatocytes, and the meiotic 
phenotype resembles Miwi2−/− mice [192, 193]. Female 
mice are fertile for each of these mutants, suggesting that 
chromosome synapsis is able to occur in meiotic oocytes 
in the absence of PIwI–piRNA function. Mael is also 
implicated in PIwI–piRNA pathways for germline genome 
defence, and is one of the few germline genome defence 
mutants where there is evidence of novel retrotranspo-
sition events taking place in the germline [191]. In the 
absence of MAeL, male mice are infertile, have defects in 
meiotic chromosome synapsis, and arrest at pachytene. A 
large increase in the levels of DNA damage is present in 
Mael−/− spermatocytes, and elegant genetic experiments 
have shown that the generation of DNA damage in Mael−/− 
spermatocytes is independent of the SPO11 endonucle-
ase that generates the meiotic DNA double-strand breaks 
required for recombination [191]. The presence of nuclear 
LINe-1 ORF1 protein correlates with high levels of the 
DNA damage marker γH2AX in Mael−/− spermatocytes, 
implying that novel DNA damage is being generated by 
retrotransposons integrating into the genome.
Maintaining suppression of retrotransposons during 
spermatogenesis appears to be important even after meiotic 
chromosome synapsis. Spermatogenesis in Miwi−/− testes 
arrests at the round spermatid stage with increased abun-
dance of LINe-1 transcripts, and elevated DNA damage 
[195, 199]. Impairing post-pachytene piRNA populations 
by conditionally deleting Mov10l1 in pachytene spermato-
cytes also causes elevated DNA damage in round sperma-
tids and spermatogenic arrest at this stage [201]. Although 
increased DNA damage and round spermatid arrest appear 
to be a consequence of a loss of piRNA-dependent MIwI 
slicer activity [199], further work is needed to determine 
whether these cellular phenotypes are caused by increased 
retrotransposon activity, or by other changes in these 
mutants. In contrast to spermatogenesis, mutations in the 
PIwI–piRNA system do not have severe defects on post-
pachytene progression through oogenesis, despite Mili−/− 
oocytes exhibiting a modest increase in retrotransposon 
expression [197].
Consequences of mutations in other germline genome 
defence mechanisms
DAZL is a germ cell-specific RNA binding protein that 
is essential for fertility in both male and female mice 
[217, 227–229]. Spermatogonial differentiation is greatly 
impaired in Dazl−/− testis, and, although a small propor-
tion of germ cells progress to meiosis, they arrest at pachy-
tene [230]. various genes have been identified that are 
translationally regulated by DAZL, including the germline 
genome defence genes Mvh and Tex19.1, and genes known 
to be important for meiosis such as Sycp3 [227, 228]. As 
DAZL translationally regulates Mvh and Tex19.1, it is 
likely that impaired translation of these genome defence 
genes accounts for some aspects of the Dazl−/− phenotype.
Unlike many of the other germline genome defence 
mutants, loss of Tex19.1 causes defects during both oogen-
esis and spermatogenesis [213]. Approximately half the 
Tex19.1−/− pachytene spermatocytes have chromosome 
synapsis defects and exhibit apoptosis at this stage, while 
two-thirds of the nuclei progressing through to metaphase I 
contain at least one set of unpaired univalent chromosomes. 
Although the retrotransposon de-repression, chromosome 
asynapsis and pachytene arrest in Tex19.1−/− males are 
all shared with the other male germline genome defence 
mutants, the spectrum of retrotransposons de-repressed in 
Tex19.1−/− testes is distinct from PIwI-piRNA pathway 
mutants [213]. TeX19.1 is stabilised by the e3 ubiquitin 
ligase UBR2 [231], but no PIwI–piRNA pathway compo-
nents have been connected to TeX19.1 or UBR2. Interest-
ingly, the de-repression of MMeRvK10C retrotransposons 
in Tex19.1−/− testes occurs in pachytene spermatocytes 
[213]; however, it is currently unclear what causes the 
chromosome synapsis defects in Tex19.1−/− spermatocytes.
Mechanisms linking retrotransposon de-repression 
to meiotic chromosome asynapsis
Mutations in germline genome defence genes tend to cause 
male-specific defects in chromosome synapsis and arrest 
meiosis during pachytene (Fig. 4), although most female 
mutants do not have a severe phenotype at this stage of 
meiosis. The cause of the chromosome asynapsis in these 
male mutants is not well understood. where reported, DNA 
double-strand breaks are generated at the start of meiosis in 
the genome defence mutants, indicating successful initia-
tion of meiotic recombination [177, 191, 213, 224]. These 
meiotic DNA double-strand breaks repair as chromosomes 
synapse, but remain unrepaired on asynapsed regions [191, 
213, 224], as would be expected from analysis of other mei-
otic mutants [232]. One informative feature of the chromo-
some asynapsis in the germline genome defence mutants is 
that the asynapsed chromosomes in these mutants are not 
paired, suggesting that the asynapsis is caused by a defect 
in the homology search rather than synaptonemal complex 
assembly.
Interestingly, Mael−/− mutants have increased amounts 
of SPO11-independent DNA damage, possibly caused 
by increased retrotransposition of LINe-1 elements, and 
these SPO11-independent DNA breaks recruit the homol-
ogous recombination protein RAD51 [191]. Thus, the 
increased DNA damage could be sequestering RAD51 and 
other meiotic recombination proteins away from meiotic 
J. H. Crichton et al.
1 3
double-strand DNA breaks generated by SPO11, thereby 
impairing the homology search. while moderate levels of 
additional DNA double-strand breaks generated by ionising 
radiation are well tolerated in spermatocytes [233], there 
appears to be a level at which DNA double-strand breaks 
become disruptive to meiotic progression. Atm−/− sper-
matocytes exhibit a tenfold increase in DNA double-strand 
breaks, which is accompanied by chromosome asynapsis 
[234]. Reducing the number of DNA double-strand breaks 
in Atm−/− spermatocytes by reducing the dosage of Spo11 
rescues the asynapsis [234]. Therefore, increased retro-
transposition creating elevated levels DNA double-strand 
breaks could be contributing to meiotic chromosome asyn-
apsis in genome defence mutants.
Although Mael−/− spermatocytes have elevated lev-
els of DNA double-strand breaks, not all genome defence 
mutants exhibit this phenotype. Unlike Mael−/− spermato-
cytes, γH2AX and RAD51 staining in Dnmt3l−/− spermat-
ocytes is relatively normal [224]. An alternative explanation 
for the defects in the meiotic homology search in genome 
defence mutants is that global changes in chromosome 
structure or organisation caused by widespread DNA hypo-
methylation could be generating an inappropriate chromo-
somal environment for the homology search. Alternatively, 
it is possible that raised levels of retrotransposon proteins 
present in genome defence mutants might be sufficient to 
disrupt the cellular environment of the developing male 
germ cells. Proteins encoded by human LTR retrotranspo-
sons physically interact with endogenous transcription fac-
tors present in germ cells and can disrupt spermatogenesis 
when ectopically expressed in transgenic mice [235–237]. 
Physical interactions between retrotransposon proteins 
and germ cell proteins involved in the meiotic homology 
search could explain the meiotic chromosome asynapsis in 
germline genome defence mutants. Further work is clearly 
needed to dissect out the mechanism causing the spermato-
cyte asynapsis and male infertility in the genome defence 
mutants.
Concluding remarks
Germline genome defence mechanisms would be expected 
to play a role in maintaining genome stability over evolu-
tionary time scales. However, it is becoming apparent that 
mutations in germline genome defence genes cause infer-
tility and defects in progression through meiosis that are 
precluding any analysis of genome stability in their off-
spring. The mechanistic explanation for this unexpected 
requirement for the germline genome defence genes is not 
understood, and it is not clear if the meiotic defects in these 
mutants are related to retrotransposon de-repression, or to 
uncharacterised meiotic functions of the germline genome 
defence genes. Imbalances between genome defence and 
retrotransposon activities could be causing infertility in 
mouse models in a similar way that incompatibilities 
between retrotransposon activity and germline genome 
defence systems cause sterility and hybrid dysgenesis in 
fruit flies [238]. It will be of interest to determine whether 
failures in germline genome defence systems, or their epi-
genetic regulation [239], could be contributing to infertility 
in humans.
The regulatory coupling of genome defence mechanisms 
to the potential for retrotransposon activity is an interesting 
paradigm that raises a number of questions. The epigenetic 
disruption and recovery screen used to identify these genes 
was performed in fibroblasts and used stringent thresholds 
for activation of gene expression [43]. Additional genome 
defence genes, such as Mael and Mvh, could be regulated 
by DNA methylation in germ cells but not identified in 
this screen due to the absence of tissue-specific transcrip-
tion factors, or the presence of additional layers of regu-
lation in fibroblasts. Therefore, more work is needed to 
better understand tissue-specific responses to epigenetic 
disruption. Furthermore, there are likely to be some dif-
ferences between the genome defence mechanisms oper-
ating in different species. Indeed, human retrotransposons 
are de-repressed in transchromosomic mice, suggesting 
that mouse genome defence mechanisms cannot effec-
tively suppress human retrotransposon sequences [240]. 
Therefore, although the links between DNA methylation, 
retrotransposon suppression and genome defence genes 
are starting to be uncovered in mice, further work will be 
required to investigate whether these associations exist in 
other species, and whether similar associations exist in 
general between different retrotransposon transcriptional 
silencing mechanisms and different groups of genome 
defence genes.
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